Back
Day Range
$52.59
$52.98
52-Week Range
$1.87
$52.98
Volume
80,783,791
50D / 200D Avg
$39.67
/
$20.49
Prev Close
$50.00
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -53.6 | 0.4 |
| P/B | 13.8 | 2.9 |
| ROE % | -29.6 | 3.9 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$55.67
+5.3%
Low: $35.00
High: $70.00
Forward EPS
-$1.18
Est. Revenue
960,000.0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$1.63
-$1.63 – -$1.63
|
40.70M | 2 |
| FY2028 |
-$1.77
-$2.32 – -$1.18
|
7.90M | 7 |
| FY2027 |
-$1.42
-$1.75 – -$0.93
|
5.77M | 8 |
No quarterly estimates available
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -70.06M
PEG of 0.42 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-29.56%
ROIC-22.00%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio23.14
Interest Coverage0.00
Valuation
P/E Ratio
-53.59
Forward P/EN/A
P/B Ratio13.77
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -88.85M |
| ROE | -29.56% | ROA | -24.41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -70.06M |
| ROIC | -22.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 23.14 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -53.59 | Forward P/E | N/A |
| P/B Ratio | 13.77 | P/S Ratio | N/A |
| PEG Ratio | 0.42 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 7988.57 |
| Forward P/S | 4959.90 | Fwd Earnings Yield | N/A |
| FCF Yield | -1.47% | ||
| Market Cap | 4.76B | Enterprise Value | 4.60B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 1.00M | 0.0 |
| Net Income | -88.85M | -90.21M | -60.35M | -50.16M | -29.35M |
| EPS (Diluted) | -1.12 | -1.27 | -1.67 | -1.98 | -1.61 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 1.00M | 0.0 |
| Operating Income | -101.87M | -102.56M | -62.03M | -49.86M | -37.03M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 363.93M | 268.52M | 287.03M | 168.07M | 92.29M |
| Total Liabilities | 18.06M | 13.15M | 10.08M | 7.77M | 23.70M |
| Shareholders' Equity | 345.87M | 255.37M | 276.94M | 160.30M | 68.59M |
| Total Debt | 1.35M | 603,000.0 | 1.21M | 0.0 | 12.88M |
| Cash & Equivalents | 161.44M | 79.93M | 143.24M | 47.70M | 74.85M |
| Current Assets | 362.11M | 267.43M | 285.19M | 166.93M | 90.87M |
| Current Liabilities | 15.65M | 11.94M | 8.47M | 6.82M | 22.82M |